Discussion
Many people with von Willebrand disease (VWD) may experience bleeding for years before being diagnosed, and some cases may still go unrecognized, according to…
Treatment with an experimental single-dose cell therapy in hard-to-manage immune thrombocytopenia (ITP) led to long-term disease control in 3 of 4 people with the rare bleeding disorder, a new study reports. The researchers stressed that these results, from a clinical trial in China testing treatment candidate PRG-1801, are preliminary and…
Latest news & perspectives
Discussion
Discussion
In a clinical trial involving adults with hard-to-treat immune thrombocytopenia (ITP), adding a 12-week course of a vitamin A-derived compound called all-trans retinoic acid…
Discussion
Starting plasma exchange — a procedure to replace a portion of a patient’s blood with that of a healthy donor — within one day of…
